<?xml version="1.0" encoding="UTF-8"?>
<rss xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:newstin="http://newstin.com/rss/module" xmlns:taxo="http://purl.org/rss/1.0/modules/taxonomy/" version="2.0">
  <channel>
    <title>Newstin - H. Lundbeck A/S</title>
    <link>http://www.newstin.co.uk/uk/H_LUNDBECK_A_S</link>
    <description>Organizing the News</description>
    <copyright>Copyright © 2006 I2S a.s.</copyright>
    <dc:rights>Copyright © 2006 I2S a.s.</dc:rights>
    <item>
      <title>08 Oct 08 | Lundbeck submits New Drug Application (NDA) for Serdolect? in the US for the...</title>
      <link>http://www.newstin.co.uk/tag/uk/80164472</link>
      <description>6253 live jobs on pharmiweb.com now 08 Oct 08 | Lundbeck submits New Drug Application (NDA) for Serdolect® in the US for the treatment of schizophrenia H. Lundbeck A/S announced today that the U.S. Food and Drug Administration...</description>
      <pubDate>Thu, 09 Oct 2008 02:55:00 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/80164472</guid>
      <dc:date>2008-10-09T02:55:00Z</dc:date>
    </item>
    <item>
      <title>Reportlinker.com: Focus on the World Alzheimer's and Parkinson's Disease Market</title>
      <link>http://www.newstin.co.uk/tag/uk/76857634</link>
      <description>LONDON, UNITED KINGDOM--(Marketwire - US, Canada, Japan, Europe, and Rest of World Independently Analyzed with Annual Sales Figures in US$ Million for Years 2011 through 2015 (includes corresponding Graph/Chart) II-62...</description>
      <pubDate>Mon, 15 Sep 2008 11:51:00 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/76857634</guid>
      <dc:date>2008-09-15T11:51:00Z</dc:date>
    </item>
    <item>
      <title>Reportlinker.com: Learn about the World CNS Therapeutics Market</title>
      <link>http://www.newstin.co.uk/tag/uk/76273687</link>
      <description>LONDON, UNITED KINGDOM--(Marketwire - World CNS Therapeutics Market http://www.reportlinker.com/p092579/World-CNS-Therapeutics-Market.html This report analyzes the worldwide markets for CNS Therapeutics in Millions of...</description>
      <pubDate>Thu, 04 Sep 2008 22:51:00 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/76273687</guid>
      <dc:date>2008-09-04T22:51:00Z</dc:date>
    </item>
    <item>
      <title>Launch of new interactive Insomnia resource for physicians</title>
      <link>http://www.newstin.co.uk/tag/uk/74997735</link>
      <description>London, England, 20th August, 2008 - EPG Health Media, developers of e-communication and clinical information solutions, today announced the launch of a new interactive Insomnia Knowledge Centre within its web-based physician...</description>
      <pubDate>Wed, 20 Aug 2008 04:39:00 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/74997735</guid>
      <dc:date>2008-08-20T04:39:00Z</dc:date>
    </item>
    <item>
      <title>Myriad Genetics slips following 4Q results</title>
      <link>http://www.newstin.co.uk/tag/uk/74816293</link>
      <description>Myriad Genetics Inc.'s fiscal fourth-quarter results generally met expectations, but the biotechnology company's stock declined in Tuesday trading. Myriad swung to a profit for the quarter. Most of its revenue came from a $100...</description>
      <pubDate>Tue, 19 Aug 2008 16:54:33 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/74816293</guid>
      <dc:date>2008-08-19T16:54:33Z</dc:date>
    </item>
    <item>
      <title>Flurizan payment pushes Myriad to fiscal 4Q profit</title>
      <link>http://www.newstin.co.uk/tag/uk/74752833</link>
      <description>SALT LAKE CITY, Utah - Biotechnology company Myriad Genetics Inc. said Tuesday it swung to a profit in its fiscal fourth quarter, boosted by a large payment for Flurizan, a since-canceled Alzheimer's disease drug candidate. In...</description>
      <pubDate>Tue, 19 Aug 2008 11:26:14 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/74752833</guid>
      <dc:date>2008-08-19T11:26:14Z</dc:date>
    </item>
    <item>
      <title>BUYINS.NET: SWDBY, TKPHY Have Also Been Removed From Naked Short List Today</title>
      <link>http://www.newstin.co.uk/tag/uk/73660326</link>
      <description>BUYINS.NET, www.buyins.net, announced today that these select companies have been removed from the NASDAQ, AMEX and NYSE naked short threshold list: Swedbank AB Sponsored ADR (OTC: SWDBY), Takeda Pharmaceutical Company Limited...</description>
      <pubDate>Tue, 12 Aug 2008 11:21:36 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/73660326</guid>
      <dc:date>2008-08-12T11:21:36Z</dc:date>
    </item>
    <item>
      <title>Interim Results: PAION AG reports half-year results 2008 and provides strategy update</title>
      <link>http://www.newstin.co.uk/tag/uk/73338486</link>
      <description>Aachen (Germany), 11 August 2008 - The biopharmaceutical company PAION AG (ISIN DE000A0B65S3; Frankfurt Stock Exchange, Prime Standard: PA8; London AIM: PAI) today announced its financial results according to International...</description>
      <pubDate>Mon, 11 Aug 2008 06:40:37 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/73338486</guid>
      <dc:date>2008-08-11T06:40:37Z</dc:date>
    </item>
    <item>
      <title>Interim Results: PAION AG Reports Half-year Results 2008 and Provides Strategy Update</title>
      <link>http://www.newstin.co.uk/tag/uk/73336409</link>
      <description>AACHEN, Germany, Aug. 11, 2008 (PRIME NEWSWIRE) -- The biopharmaceutical company PAION AG (ISIN DE000A0B65S3) (Frankfurt:PA8) (London AIM:PAI) today announced its financial results according to International Financial Reporting...</description>
      <pubDate>Mon, 11 Aug 2008 06:10:00 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/73336409</guid>
      <dc:date>2008-08-11T06:10:00Z</dc:date>
    </item>
    <item>
      <title>Correction: Total number of voting rights and size of share capital as of 31 July 2008 after reduc..</title>
      <link>http://www.newstin.co.uk/tag/uk/71452306</link>
      <description>On 22 April 2008, the Annual General Meeting of H. Lundbeck A/S resolved to reduce the company's share capital by a nominal amount of DKK 51,966,745 by reducing the company's holding of treasury shares. The resolution was...</description>
      <pubDate>Thu, 31 Jul 2008 07:34:13 GMT</pubDate>
      <guid>http://www.newstin.co.uk/tag/uk/71452306</guid>
      <dc:date>2008-07-31T07:34:13Z</dc:date>
    </item>
  </channel>
</rss>

